Erectile Dysfunction Drugs Market Report

Erectile Dysfunction Drugs Market Analysis By Product (Viagra, Levitra/Staxyn, Stendra/Spedra, Zydena, Vitaros), And Segment Forecasts To 2022

  • Published Date: Jul, 2016
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-604-2
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 70

Market segmentation

  • Global Erectile Dysfunction Drugs Product Outlook (Revenue, USD Million, 2012 - 2022)

    • Viagra (sildenafil citrate)
    • Cialis (tadalafil)
    • Levitra/ staxyn (Vardenafil)
    • Stendra/Spedra (avanafil)
    • Zydena (udenafil)
    • Vitaros (alprostadil)
    • Others
  • Erectile Dysfunction Drugs Regional Outlook (Revenue, USD Million, 2012 - 2022)

    • North America
      • Erectile dysfunction drugs Product Outlook (Revenue, USD Million, 2012 - 2022)
        • Viagra (sildenafil citrate)
        • Cialis (tadalafil)
        • Levitra/ staxyn (Vardenafil)
        • Stendra/Spedra (avanafil)
        • Zydena (udenafil)
        • Vitaros (alprostadil)
        • Others
    • Europe
      • Erectile dysfunction drugs Product Outlook (Revenue, USD Million, 2012 - 2022)
        • Viagra (sildenafil citrate)
        • Cialis (tadalafil)
        • Levitra/ staxyn (Vardenafil)
        • Stendra/Spedra (avanafil)
        • Zydena (udenafil)
        • Vitaros (alprostadil)
        • Others
    • Asia Pacific
      • Erectile dysfunction drugs Product Outlook (Revenue, USD Million, 2012 - 2022)
        • Viagra (sildenafil citrate)
        • Cialis (tadalafil)
        • Levitra/ staxyn (Vardenafil)
        • Stendra/Spedra (avanafil)
        • Zydena (udenafil)
        • Vitaros (alprostadil)
        • Others
    • Latin America
      • Erectile dysfunction drugs Product Outlook (Revenue, USD Million, 2012 - 2022)
        • Viagra (sildenafil citrate)
        • Cialis (tadalafil)
        • Levitra/staxyn (Vardenafil)
        • Stendra/spedra (avanafil)
        • Zydena (udenafil)
        • Vitaros (alprostadil)
        • Others
    • MEA
      • Erectile dysfunction drugs Product Outlook (Revenue, USD Million, 2012 - 2022)
        • Viagra (sildenafil citrate)
        • Cialis (tadalafil)
        • Levitra/staxyn (Vardenafil)
        • Stendra/spedra (avanafil)
        • Zydena (udenafil)
        • Vitaros (alprostadil)
        • Others 

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments 

Quantitative Analysis

  • Market size, estimates, and forecast from 2012 to 2022
  • Revenue estimates for product up to 2022
  • Regional market size and forecast for product up to 2022
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.